Literature DB >> 6259323

Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.

C S Sweet, D M Gross, P T Arbegast, S L Gaul, P M Britt, C T Ludden, D Weitz, C A Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6259323

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  16 in total

Review 1.  Preclinical studies on angiotensin converting enzyme inhibitors.

Authors:  I L Natoff
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

2.  Lisinopril in hypertensive patients with and without renal failure.

Authors:  B A van Schaik; G G Geyskes; P Boer
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Absence of a pharmacokinetic interaction between enalapril and frusemide.

Authors:  A M Van Hecken; R Verbesselt; A Buntinx; V J Cirillo; P J De Schepper
Journal:  Br J Clin Pharmacol       Date:  1987-01       Impact factor: 4.335

Review 4.  An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development.

Authors:  H S Buttar
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

Review 5.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

6.  Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.

Authors:  J A Millar; F H Derkx; K McLean; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

7.  Enalapril maleate and a lysine analogue (MK-521): disposition in man.

Authors:  E H Ulm; M Hichens; H J Gomez; A E Till; E Hand; T C Vassil; J Biollaz; H R Brunner; J L Schelling
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

8.  Relation of plasma renin activity to the antihypertensive effect of MK 421 in the rat.

Authors:  D Bradshaw; P H Franz; A L Sugden
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

Review 9.  An overview of the clinical pharmacology of enalapril.

Authors:  R O Davies; H J Gomez; J D Irvin; J F Walker
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

Review 10.  Intravenous vasodilator therapy in congestive heart failure.

Authors:  Kourosh Moazemi; Jatinder S Chana; Anna Marie Willard; Abraham G Kocheril
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.